-
Sector Analysis
Competitor Landscape: Spondyloarthritis
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the spondyloarthritis (SpA) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Sector Analysis
Competitor Landscape: HIV
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the HIV market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Sector Analysis
Competitor Landscape: Lupus
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Lupus market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Sector Analysis
Competitor Landscape: Inflammatory Bowel Disease (IBD)
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the IBD market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Sector Analysis
Competitor Landscape: Non-alcoholic Steatohepatitis (NASH)
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the NASH market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Sector Analysis
Competitor Landscape: Renal Anemia
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Renal Anemia market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Sector Analysis
Quarterly Beverage Tracker First Quarter 2016: Slovenia; Comprehensive Quarterly Analysis of Year on Year Performance for All Commercial Beverages
On-premise consumption of beverage products reported positive development, although Q1-16 was the off-season. Beer consumption remained broadly stable in Q1-16, due to its popularity and sociable image. FABs, from a low base, saw the largest expansion in Q1-16 because of the variety of popular pre-made cocktails. Dairy drinks consumption remained broadly stable in Q1-16, supported by promotional discounts and cheap imported milk. Consumption of hot beverages was driven by promotional discounts and influenced by weather conditions in Q1-16.